vs
Side-by-side financial comparison of Envela Corp (ELA) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.
Envela Corp is the larger business by last-quarter revenue ($80.5M vs $41.8M, roughly 1.9× Neuronetics, Inc.). Envela Corp runs the higher net margin — 7.4% vs -17.2%, a 24.7% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs 66.6%). Neuronetics, Inc. produced more free cash flow last quarter ($692.0K vs $-3.7M). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 42.1%).
Envela Corporation is a U.S.-based company that provides recommerce services aimed at extending product lifecycles and reducing resource consumption. The company operates through two primary segments: consumer and commercial.
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
ELA vs STIM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $80.5M | $41.8M |
| Net Profit | $6.0M | $-7.2M |
| Gross Margin | 20.5% | 52.0% |
| Operating Margin | 9.4% | -12.1% |
| Net Margin | 7.4% | -17.2% |
| Revenue YoY | 66.6% | 85.7% |
| Net Profit YoY | 274.6% | 43.2% |
| EPS (diluted) | $0.22 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $80.5M | $41.8M | ||
| Q3 25 | $57.4M | $37.3M | ||
| Q2 25 | $54.9M | $38.1M | ||
| Q1 25 | $48.3M | $32.0M | ||
| Q4 24 | $48.3M | $22.5M | ||
| Q3 24 | $46.9M | $18.5M | ||
| Q2 24 | $45.3M | $16.4M | ||
| Q1 24 | $39.9M | $17.4M |
| Q4 25 | $6.0M | $-7.2M | ||
| Q3 25 | $3.4M | $-9.0M | ||
| Q2 25 | $2.8M | $-10.1M | ||
| Q1 25 | $2.5M | $-12.7M | ||
| Q4 24 | $1.6M | $-12.7M | ||
| Q3 24 | $1.7M | $-13.3M | ||
| Q2 24 | $1.6M | $-9.8M | ||
| Q1 24 | $1.9M | $-7.9M |
| Q4 25 | 20.5% | 52.0% | ||
| Q3 25 | 22.8% | 45.9% | ||
| Q2 25 | 22.6% | 46.6% | ||
| Q1 25 | 24.8% | 49.2% | ||
| Q4 24 | 23.1% | 66.2% | ||
| Q3 24 | 24.4% | 75.6% | ||
| Q2 24 | 25.1% | 74.0% | ||
| Q1 24 | 25.9% | 75.1% |
| Q4 25 | 9.4% | -12.1% | ||
| Q3 25 | 7.3% | -19.6% | ||
| Q2 25 | 5.9% | -21.1% | ||
| Q1 25 | 6.5% | -34.4% | ||
| Q4 24 | 3.9% | -51.0% | ||
| Q3 24 | 4.3% | -41.7% | ||
| Q2 24 | 4.2% | -51.7% | ||
| Q1 24 | 5.9% | -39.4% |
| Q4 25 | 7.4% | -17.2% | ||
| Q3 25 | 5.8% | -24.3% | ||
| Q2 25 | 5.0% | -26.6% | ||
| Q1 25 | 5.2% | -39.6% | ||
| Q4 24 | 3.3% | -56.4% | ||
| Q3 24 | 3.6% | -72.0% | ||
| Q2 24 | 3.5% | -59.8% | ||
| Q1 24 | 4.8% | -45.2% |
| Q4 25 | $0.22 | $-0.10 | ||
| Q3 25 | $0.13 | $-0.13 | ||
| Q2 25 | $0.11 | $-0.15 | ||
| Q1 25 | $0.10 | $-0.21 | ||
| Q4 24 | $0.07 | $-0.34 | ||
| Q3 24 | $0.06 | $-0.44 | ||
| Q2 24 | $0.06 | $-0.33 | ||
| Q1 24 | $0.07 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $28.1M |
| Total DebtLower is stronger | $9.9M | $65.8M |
| Stockholders' EquityBook value | $67.1M | $22.4M |
| Total Assets | $96.0M | $141.6M |
| Debt / EquityLower = less leverage | 0.15× | 2.94× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $28.1M | ||
| Q3 25 | — | $28.0M | ||
| Q2 25 | — | $11.0M | ||
| Q1 25 | — | $20.2M | ||
| Q4 24 | — | $18.5M | ||
| Q3 24 | — | $20.9M | ||
| Q2 24 | — | $42.6M | ||
| Q1 24 | $19.8M | $47.7M |
| Q4 25 | $9.9M | $65.8M | ||
| Q3 25 | $12.5M | $65.7M | ||
| Q2 25 | $13.0M | $55.5M | ||
| Q1 25 | $13.2M | $55.3M | ||
| Q4 24 | $13.5M | $55.2M | ||
| Q3 24 | $13.8M | $46.0M | ||
| Q2 24 | $14.3M | $59.8M | ||
| Q1 24 | $14.6M | $59.4M |
| Q4 25 | $67.1M | $22.4M | ||
| Q3 25 | $61.1M | $27.4M | ||
| Q2 25 | $57.8M | $27.1M | ||
| Q1 25 | $55.1M | $35.5M | ||
| Q4 24 | $52.7M | $27.7M | ||
| Q3 24 | $51.1M | $9.4M | ||
| Q2 24 | $50.2M | $19.4M | ||
| Q1 24 | $49.3M | $27.7M |
| Q4 25 | $96.0M | $141.6M | ||
| Q3 25 | $90.9M | $145.5M | ||
| Q2 25 | $82.7M | $134.7M | ||
| Q1 25 | $79.7M | $142.0M | ||
| Q4 24 | $77.9M | $140.9M | ||
| Q3 24 | $77.4M | — | ||
| Q2 24 | $73.8M | $96.8M | ||
| Q1 24 | $74.7M | $103.8M |
| Q4 25 | 0.15× | 2.94× | ||
| Q3 25 | 0.20× | 2.40× | ||
| Q2 25 | 0.23× | 2.05× | ||
| Q1 25 | 0.24× | 1.56× | ||
| Q4 24 | 0.26× | 1.99× | ||
| Q3 24 | 0.27× | 4.90× | ||
| Q2 24 | 0.29× | 3.08× | ||
| Q1 24 | 0.30× | 2.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.5M | $908.0K |
| Free Cash FlowOCF − Capex | $-3.7M | $692.0K |
| FCF MarginFCF / Revenue | -4.6% | 1.7% |
| Capex IntensityCapex / Revenue | 0.2% | 0.5% |
| Cash ConversionOCF / Net Profit | -0.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.4M | $-21.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.5M | $908.0K | ||
| Q3 25 | $2.4M | $-785.0K | ||
| Q2 25 | $2.6M | $-3.5M | ||
| Q1 25 | $1.1M | $-17.0M | ||
| Q4 24 | $3.7M | $-8.6M | ||
| Q3 24 | $3.4M | $-5.4M | ||
| Q2 24 | $-789.5K | $-5.0M | ||
| Q1 24 | $3.8M | $-12.0M |
| Q4 25 | $-3.7M | $692.0K | ||
| Q3 25 | $2.2M | $-899.0K | ||
| Q2 25 | $2.1M | $-3.8M | ||
| Q1 25 | $746.6K | $-17.2M | ||
| Q4 24 | $3.2M | $-8.7M | ||
| Q3 24 | $1.5M | $-5.8M | ||
| Q2 24 | $-1.3M | $-5.6M | ||
| Q1 24 | $3.3M | $-12.4M |
| Q4 25 | -4.6% | 1.7% | ||
| Q3 25 | 3.8% | -2.4% | ||
| Q2 25 | 3.9% | -9.9% | ||
| Q1 25 | 1.5% | -53.8% | ||
| Q4 24 | 6.7% | -38.6% | ||
| Q3 24 | 3.1% | -31.3% | ||
| Q2 24 | -2.9% | -34.0% | ||
| Q1 24 | 8.4% | -71.1% |
| Q4 25 | 0.2% | 0.5% | ||
| Q3 25 | 0.4% | 0.3% | ||
| Q2 25 | 0.8% | 0.7% | ||
| Q1 25 | 0.8% | 0.7% | ||
| Q4 24 | 1.0% | 0.4% | ||
| Q3 24 | 4.2% | 2.1% | ||
| Q2 24 | 1.1% | 3.7% | ||
| Q1 24 | 1.1% | 2.2% |
| Q4 25 | -0.59× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 0.94× | — | ||
| Q1 25 | 0.45× | — | ||
| Q4 24 | 2.34× | — | ||
| Q3 24 | 2.05× | — | ||
| Q2 24 | -0.50× | — | ||
| Q1 24 | 1.99× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELA
| Consumer Segment | $67.7M | 84% |
| Commercial Segment | $12.8M | 16% |
STIM
Segment breakdown not available.
